About
I bring an eclectic and multidisciplinary background, which enables me to adapt quickly, assimilate new knowledge, and drive impactful outcomes. My expertise spans targeted delivery systems, advanced therapeutics, and medical device technologies, where I contribute both as an independent researcher and collaborative team member with a strong results-oriented approach. My mission is to advance the next generation of targeted delivery platforms and medical therapies, bridging innovation with clinical practice to improve patient outcomes worldwide. Alongside research, I aim to mentor and inspire future scientists, fostering innovation that shapes the evolving field of advanced medical interventions. My professional experience includes developing and curating drug databases, authoring and reviewing manuscripts, abstracts, and slide decks, and ensuring high-quality scientific communication.
Experience
Manager
Freyr Global Regulatory Solutions and Services
o Prepare a literature review, abstracts, posters, brochures, and presentations based on several data sources, such as clinical study reports, patient profiles, protocols, etc. o Draft/review critical, highly complex manuscripts detailing safety and efficacy data from pivotal clinical studies for publication in high-impact journals. o Support Global Medical Affairs with key communication deliverables, initiatives involving stakeholder engagement, and scientific events. o Provide an expert review of publications drafted as per publication guidelines (ICMJE, GPP3, EQUATOR, EASE, AMWA, STM) and applicable ethical regulations (COPE). o Posted and promoted articles on social media platforms to engage target audience.
Assistant Manager
TCS Ltd
o Prepare a literature review, abstracts, posters, and brochures. o Provide an expert review of publications drafted as per publication guidelines. o Performs Quality check for the Deliverables.
Academician, Professor & Scientific Writer
Gupta College of Pharmacy
o Teaching and research activities engaged for graduate, post-graduate, and research scholars in pharmaceutical sciences. o Supervision of formulation development, Optimization & Characterization for Micro and Nanoparticles. o Wrote and published peer-reviewed articles concerning findings and highlighted possible applications for findings. o Collaborated with different department professionals to advance research and gain deeper understanding of topics. o Participated in discussions, seminars, and lectures at departmental events. o Authored professional scientific papers for publishing in peer-reviewed journals. o Successfully implemented various projects funded from Govt. of India like NCSTC, SERB, AICTE, ICMR.
Academician, Assoc. Prof. & Scientific Writer
Vishwabharathi College of Pharmacy
o Teaching and research activities engaged for graduate, post-graduate, and research scholars in pharmaceutical sciences. o Supervision of formulation development, Optimization & Characterization for Micro and Nanoparticles. o Wrote and published peer-reviewed articles concerning findings and highlighted possible applications for findings. o Collaborated with different department professionals to advance research and gain deeper understanding of topics. o Participated in discussions, seminars, and lectures at departmental events. o Authored professional scientific papers for publishing in peer-reviewed journals. o Successfully implemented various projects funded from Govt. of India like NCSTC, SERB, AICTE, ICMR.
Academician, Assoc. Prof. & Scientific Writer
Sarada College of Pharmacy
o Teaching and research activities engaged for graduate, post-graduate, and research scholars in pharmaceutical sciences. o Supervision of formulation development, Optimization & Characterization for Micro and Nanoparticles. o Wrote and published peer-reviewed articles concerning findings and highlighted possible applications for findings. o Collaborated with different department professionals to advance research and gain deeper understanding of topics. o Participated in discussions, seminars, and lectures at departmental events. o Authored professional scientific papers for publishing in peer-reviewed journals. o Successfully implemented various projects funded from Govt. of India like NCSTC, AICTE, ICMR.
Researcher, Assoc. Prof. & Scientific Writer
Siddhartha institute of Pharmacy
o Teaching and research activities engaged for graduate, post-graduate, and research scholars in pharmaceutical sciences. o Supervision of formulation development, Optimization & Characterization for Micro and Nanoparticles. o Wrote and published peer-reviewed articles concerning findings and highlighted possible applications for findings. o Collaborated with different department professionals to advance research and gain deeper understanding of topics. o Participated in discussions, seminars, and lectures at departmental events. o Authored professional scientific papers for publishing in peer-reviewed journals. o Successfully implemented various projects funded from Govt. of India like NCSTC, AICTE, ICMR.
Researcher, Asst. Prof. & Scientific Writer
Vishwabharathi College of Pharmacy
o Teaching and research activities engaged for graduate, post-graduate, and research scholars in pharmaceutical sciences. o Wrote and published peer-reviewed articles concerning findings and highlighted possible applications for findings. o Collaborated with different department professionals to advance research and gain deeper understanding of topics. o Participated in discussions, seminars, and lectures at departmental events. o Authored professional scientific papers for publishing in peer-reviewed journals. o Successfully implemented various projects funded from Govt. of India like SERB.
Researcher & Asst. Prof.
Srinivasa institute of Pharmacy
o Teaching and research activities engaged for graduate, post-graduate, and research scholars in pharmaceutical sciences. o Wrote and published peer-reviewed articles concerning findings and highlighted possible applications for findings. o Participated in discussions, seminars, and lectures at departmental events. o Authored professional scientific papers for publishing in peer-reviewed journals.
Education
M.M. University - Ambala, Haryana
Ph.D.: Pharmaceutical Sciences
Osmania University
M.Pharmacy- Pharmaceutics
Acharya Nagarjuna University
B.Pharmacy
Skills
Other Publications
Enhanced rivastigmine delivery through nanoemulsion and pyridoxine supplementation: An in-vivo study on Alzheimer's disease intervention
Nanomedicine: Nanotechnology, Biology and Medicine, Apr 2025
Nanoemulsions are nanostructured material and stabilized colloidal in nature evolved as a highly desirable mechanism for the delivery of drugs. Our objective of the study deals with a successful Rivastigmine (RSG) loaded nanoemulsion which can effectively progress the treatment of AD patients. We developed nanoemulsion containing RSG by combining pyridoxine, an essential vitamin supplement for central nervous system development, with linseed oil, which functioned as the lipophilic phase in the nanoemulsion formulation. The optimal formulation having globular size of 202.3 nm was further evaluated by various analytical techniques, including zeta potential analysis, ATR, DSC, and XRD study. The study utilized the Morris Water Maze (MWM) model to assess the cognitive abilities of Long-Evans rats. The current investigation establishes that the utilization of RSG nanoemulsion incorporating blend of linseed oil and pyridoxine which reduced travel distance in animal mode and can be success
Novel delivery strategy: finasteride-loaded solid lipid nanoparticles for improved androgenetic alopecia therapy
RSC advances, May 2025
Androgenetic alopecia (AGA) is currently the most prevalent cause of hair loss on the scalp. The daily administration of finasteride (FINA) by oral route may lead to the development of numerous undesirable systemic side effects. However, commercially available dermal dosage forms are available only with minoxidil; few studies have claimed severe side effects. Our study deals with the development of solid lipid nanoparticles (SLNs) of FINA with a suitable combination of L-α-phosphatidylcholine (LPC) and N-trimethyl chitosan (NTC) to overcome limitations along with good skin retention and hair growth. FINA-SLNs were developed using the ultrasonication technique and characterized further, along with hair growth observed in the animal model. The formulation NP7 showed the highest zeta potential value of −16.5 mV. The absence of the [double bond, length as m-dash]NH peak in the 1H-NMR spectra could be due to the protons attached, which have substantial exchangeability and result in a probable disappearance in the NMR spectra. The investigation showed the highest skin retention of 226.76 μg of FINA by NP7, along with a modest amount of FINA permeated (71.23 μg) during the study period of 18 h. The animal model using C57BL/6 mice showed a notable enhancement in hair covering and growth in Group IV, which received treatment without any visible cutaneous reaction on the skin. This outcome underscores the effectiveness and importance of the formulation developed using a suitable combination of LPC and NTC, which could be used to manage AGA effectively.
From nature to nanomedicine: bioengineered metallic nanoparticles bridge the gap for medical applications
Discover Nano, May 2024
The escalating global challenge of antimicrobial resistance demands innovative approaches. This review delves into the current status and future prospects of bioengineered metallic nanoparticles derived from natural sources as potent antimicrobial agents. The unique attributes of metallic nanoparticles and the abundance of natural resources have sparked a burgeoning field of research in combating microbial infections. A systematic review of the literature was conducted, encompassing a wide range of studies investigating the synthesis, characterization, and antimicrobial mechanisms of bioengineered metallic nanoparticles. Databases such as PubMed, Scopus, Web of Science, ScienceDirect, Springer, Taylor & Francis online and OpenAthen were extensively searched to compile a comprehensive overview of the topic. The synthesis methods, including green and sustainable approaches, were examined, as were the diverse biological sources used in nanoparticle fabrication. The amalgamation of metallic nanoparticles and natural products has yielded promising antimicrobial agents. Their multifaceted mechanisms, including membrane disruption, oxidative stress induction, and enzyme inhibition, render them effective against various pathogens, including drug-resistant strains. Moreover, the potential for targeted drug delivery systems using these nanoparticles has opened new avenues for personalized medicine. Bioengineered metallic nanoparticles derived from natural sources represent a dynamic frontier in the battle against microbial infections. The current status of research underscores their remarkable antimicrobial efficacy and multifaceted mechanisms of action. Future prospects are bright, with opportunities for scalability and cost-effectiveness through sustainable synthesis methods. However, addressing toxicity, regulatory hurdles, and environmental considerations remains crucial. In conclusion, this review highlights the evolving landscape of bioengineered metallic nanoparticles, offering valuable insights into their current status and their potential to revolutionize antimicrobial therapy in the future.
Hybrid silver nanoparticles: Modes of synthesis and various biomedical applications
Electron, May 2024
In the present day, there is a growing trend of employing new strategies to synthesize hybrid nanoparticles, which involve combining various functionalities into a single nanocomposite system. These modern methods differ significantly from the traditional classical approaches and have emerged at the forefront of materials science. The fabrication of hybrid nanomaterials presents an unparalleled opportunity for applications in a wide range of areas, including therapy to diagnosis. The focus of this review article is to shed light on the different modalities of hybrid nanoparticles, providing a concise description of hybrid silver nanoparticles, exploring various modes of synthesis and classification of hybrid silver nanoparticles, and highlighting their advantages. Additionally, we discussed core-shell silver nanoparticles and various types of core and shell combinations based on the material category, such as dielectric, metal, or semiconductor. The two primary classes of hybrid silver nanoparticles were also reviewed. Furthermore, various hybrid nanoparticles and their methods of synthesis were discussed but we emphasize silica as a suitable candidate for hybridization alongside metal nanoparticles. This choice is due to its hydrophilic surface qualities and high surface charge, which provide the desired repulsive forces to minimize aggregation between the metal nanoparticles in the liquid solution. Silica shell encapsulation also provides chemical inertness, robustness and the adaptability to the desired hybrid nanoparticle. Therefore, among all the materials used to coat metal nanoparticles; silica is highly approved.
Implementation and effect estimation by Taguchi orthogonal array design for Metoprolol Sustained Release Tablets
Smart Science, Jul 2023
The purpose of this study was to evaluate the influence of variables on dosage form development using a Taguchi orthogonal array design. By implementing the design, a total of nine sustained-release Metoprolol tartrate tablet formulations were created. In addition to four responses, four independent variables, including METHOCEL K15M, HPMC K100, Guar gum, and Pectic polysaccharide, were analyzed. In addition to evaluating formulations for hardness, swelling index, drug release percentage, and friability, a release kinetics study is conducted. Half normal plots and interaction plots were drawn to identify significant factors and study their interactions. The data were analyzed using statistical modeling, with the process order being design model and the model type being factorial with main effect determination. Formulation ‘F1’ was determined to be the best and most optimized formulation, and it was further characterized by attenuated total reflectance, differential scanning calorimetry, and X-ray diffraction studies. Additionally, the formulation was evaluated for stability in accordance with ICH guidelines, which revealed that it was sufficiently stable.
Formulation, optimization and characterization of raloxifene hydrochloride loaded PLGA nanoparticles by using Taguchi design for breast cancer application
Chemical Biology & Drug Design, Mar 2023
Multidrug resistance in breast cancer and the associated side-effects of anticancer therapies are significant hurdles in chemotherapy-based treatment. Biodegradable polymeric nano-based targeted drug delivery technologies showed tremendous advantages in targeted local delivery with limited off-targeted side effects. Therefore, there is a persistent need to develop targeted nanomedicine systems for treatment of breast cancer. The current research attempted to develop poly (lactic-co-glycolic acid) nanoparticles loaded with raloxifene by modified emulsification solvent diffusion evaporation method to improve oral bioavailability by using Taguchi design. It was observed that the optimized formulation (1:4 drug to polymer ratio) poly (lactic-co-glycolic acid) showed a mean particle size and Polydispersity index of 218 ± 23.7 nm and 0.231 ± 0.04, respectively. The entrapment efficiency was found to be 82.30% ± 1.02%. In vitro drug delivery was found to be 92.5% ± 1.48% in 40 h. The nanoparticles were to remain stable at 2°C–8°C even after 30 days. Differential scanning calorimetry and Fourier transform infrared spectroscopy characterization techniques showed that there was no interaction between the drug and excipient. Stability studies indicate that polymeric nanoparticles were stable at 2°C–8°C after 6 months. Raloxifene nanoparticles may be the most potent targeting moieties to treat highly invasive and metastatic MCF-7 breast cancer cells.
Hyaluronic Acid-Based Bioconjugate Systems, Scaffolds, and Their Therapeutic Potential
Advanced healthcare materials , Mar 2023
In recent years, the development of hyaluronic acid or hyaluronan (HA) based scaffolds, medical devices, bioconjugate systems have expanded into a broad range of research and clinical applications. Research findings over the last two decades suggest that the abundance of HA in most mammalian tissues with distinctive biological roles and chemical simplicity for modifications have made it an attractive material with a rapidly growing global market. Besides its use as native forms, HA has received much interest on so-called “HA-bioconjugates” and “modified-HA systems”. In this review, the importance of chemical modifications of HA, underlying rationale approaches, and various advancements of bioconjugate derivatives with their potential physicochemical, and pharmacological advantages are summarized. This review also highlights the current and emerging HA-based conjugates of small molecules, macromolecules, crosslinked systems, and surface coating strategies with their biological implications, including their potentials and key challenges discussed in detail.
Perspectives on cutting-edge nanoparticulate drug delivery technologies based on lipids and their applications
Chemical Biology & Drug Design, Mar 2023
Numerous nanotech arenas in therapeutic biology have recently provided a scientific platform to manufacture a considerable swath of unique chemical entities focusing on drugs. Recently, nanoparticulate drug delivery systems have emerged to deliver a specific drug to a specified site. Among all other carriers, lipids possess features exclusive to nanostructured dosage forms. The bioavailability of orally administered drugs is typically negatively affected by their poor water solubility, resulting from the unique chemical moieties introduced. Because of their unique advantages, lipid nanoparticles must become increasingly predictable as a robust delivery mechanism. The enhanced biopharmaceutical properties and significance of lipid-based targeting technologies such as liposomes, niosomes, solid lipid nanoparticles and micelles are highlighted in this review. Pharmaceutical implications of lipid nanocarriers for the transport and distribution of various therapeutic agents, such as biotechnological products and small pharmaceutical molecules, is a booming topic. Lipid nanoparticles as drug delivery systems have many appealing properties, including high biocompatibility, ease of preparation, tissue specificity, avoidance of reticuloendothelial systems, delayed drug release, scale-up feasibility, nontoxicity and targeted delivery. The use of lipid nanoparticles to enhance the transport of biopharmaceuticals is currently considered state-of-the-art. Similarly, we critically examine the upcoming guidelines that therapeutic scientists should handle.
Duloxetine hydrochloride enteric-coated pellets in capsules with delayed release: formulation and evaluation
Smart Science, Mar 2023
The primary purpose of this study is to develop and evaluate an effective and reliable delayed-release dosage form of Duloxetine hydrochloride enteric-coated pellets in capsules. Duloxetine hydrochloride dissolves in an acidic environment, yet pellets maintain their enteric coating due to the Wurster expansion process for the Fluidized Bed Processor. Four distinct layers comprise enteric-coated pellets: a pharmaceutical layer, a barrier layer, an enteric layer, and a coating on the inert core pellets. A suspension layering approach protects the acidic environment from the drug by coating it with an enteric layer composed of hydroxyl propyl methyl cellulose phthalate HP55. We also determined the bulk and tapped densities, Hausner’s ratio, compressibility index, and moisture content of all formulations. The produced pellets are being evaluated for in-vitro release tests using UV-Visible spectroscopy. The zero-order model, the first-order model, and Higuchi’s square root equation, Hixson-Crowell, Korsemeyer peppas, and the Weibull model were used to evaluate the released kinetics models. Investigations using FT-IR (infrared spectroscopy) are still being undertaken to determine the drug’s compatibility with various excipients. Formulation ‘F7’ exhibited highest similarity factor of 56.1. Stability tests conducted over a three-month period under accelerated settings established that the optimized formulation is stable.
Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs
Bulletin of the National Research Centre, Jun 2023
Background Methicillin-resistant Staphylococcus aureus (MRSA) is a common bacterial infection that is a significant source of illness and mortality globally. The advancements in antibiotic therapies continue to be the critical aspects of treating bacterial infections, and their usage has lowered patient mortality and raised life expectancy. Main body of the abstract The ideal treatments for MRSA remain challenging, and the quest for new antibiotic targets and advanced drug delivery systems with safety profiles is necessary to ensure treating MRSA infections adequately in the future. Short conclusion This article primarily focuses on different therapeutic medications and their modes of action for general microbial infections and goes through the latest developments in novel drug delivery technologies, such as hydrogels, lipid particles, nanocarriers, and polymers for MRSA treatment.
Formulation, Characterization, and Taguchi Design Study of Eplerenone Lipid-Based Solid Dispersions Integrated with Gelucire
BioNanoScience, Apr 2023
Eplerenone is a potassium-sparing diuretic of aldosterone antagonist employed to treat chronic heart failure and high blood pressure. Eplerenone is classified as a BSC class II drug since it has poor oral absorption and is difficult to absorb in the body. The solid dispersions approach is the most practical and least expensive method to increase the solubility and dissolution rate of poorly water-soluble eplerenone. Formulating lipid-based solid dispersions employing a mix of hydrophilic lipid carriers has shown to be quite common. Gelucire 50/13 and Gelucire 44/14 were both in there. These compositions included a range of different concentrations and ratios, including 1:1, 1:3, and 1:5, and their phase solubility properties were tested. A comparison was made between in vitro dissolving results of our product and those of the market using 7.4 pH phosphate buffer. FTIR, DSC, and XRD characterized the lipid-based solid dispersions. The crystalline structure of eplerenone was ameliorated. The commercial medicine was 85% dissolved after 2 h, while F3 dissolved at 99% in the same timeframe. It was discovered that 4 h after starting the ex vivo permeation study, the permeability of eplerenone was 51%, the penetration of the commercial medication was 76%, and the permeation of formulation F3 was 81%. Taguchi design explored significant factors contributed responses. Eplerenone is better absorbed and transported with the help of formulation F3. To investigate permeability further, ex vivo tests were undertaken with impressive results compared to what was available on the market.
Physiological Pathway, diagnosis and nanotechnology based treatment strategies for ovarian Cancer: A review
Medicine in Omics, Jun 2023
Ovarian cancer is a fatal disease requiring great attention from the scientific community to find novel ways for diagnosis and treatment. Most ovarian malignancies, or 90% of cases, are epithelial ovarian cancers. HGSC (High Grade Ovarian Cancer) is the most prevalent subtype, and the majority of women who are diagnosed with it eventually develop resistance to standard treatments. Expression of genes linked to these immune pathways and increased cytotoxic immune cell infiltration is primarily associated with HGSC cancer that shows DNA damage repair gene deficiency and high chromosomal instability. Currently, chemotherapy, radiation, and cytoreduction are the most common forms of treatment; nevertheless, in the absence of targeted therapies, patients experience unfavorable side effects and develop drug resistance. It is critical to understand the intricate biology of the disease and find relevant biomarkers in order to make an early diagnosis or anticipate how a patient will respond to a given treatment. Interferon activating medicines have been studied as a potential means of enhancing anti-tumor immunity in ovarian cancer. Chemical and biological nano-sensors have also been developed to detect different types of cancers, including ovarian cancer. Further, the application of nanotechnology for diagnostic and therapeutic purposes makes it a more convenient, target-specific, and side effect free delivery system for ovarian cancer treatment. A combination of nanotechnology with the physiological biomarkers and therapeutic agents created a novel system of nano theranostics, which have the potential of real-time monitoring and diagnosis and simultaneous delivery of the therapeutic agent for the treatment of ovarian cancer.
Food and drug industry applications of microalgae Spirulina platensis: A review
Journal of basic microbiology, Jan 2023
Spirulina platensis is a photosynthetic, blue-green, spiral- or bulb-shaped microalgae. Due to the presence of minerals, vitamins, pigments (carotenes, phycocyanin and chlorophyll) proteins (55%–70%), carbohydrates (15%–25%), and essential fatty acids (5%–8%), it has been used as a nutritional supplement for decades. NASA successfully employed it as a nutritional supplement for astronauts on space missions then its popularity was increased. The chemical composition of Spirulina, which is rich in vitamins, minerals, phenolics, vital fatty acids, amino acids, and pigments, can be beneficial to human health when incorporated into meals. The pharmacological effects include antibacterial, anticancer, metalloprotective, immune-stimulating, and antioxidant. It modulates immunological activities and possesses anti-inflammatory qualities by preventing mast cells from releasing histamine. Due to its high quantity of protein, carbohydrate, lipid, vital amino and fatty acids, dietary minerals and vitamins, Spirulina exerts the abovementioned benefits. In this review, up-to-date and possible biological aspects, patents applied on Spirulina and heights of confirmation are addressed, and the extent of current and future exploration is also explored.
Citicoline loaded nanoemulsion enriched with D-alpha-Tocopherol acetate and protein: Formulation and in-silico study
Journal of Drug Delivery Science and Technology, Apr 2023
Nanoemulsion, a nanostructured and colloidal dosage form, have emerged as a promising drug delivery system. Crossing the blood-brain barrier (BBB), effectively targeting the brain, and treating Alzheimer's disease (AD) are still formidable challenge. Citicoline (CL) nanoemulsion was developed utilizing D-alpha-Tocopherol acetate (DAT) as the emulsifier and BBB permeability enhancer, Bovine serum albumin (BSA) as the protein, and Poly lactide-co-glycolic acid (PLGA) as the release retardant. The binding affinity and suitability of DAT towards acetylcholinesterase was determined using molecular docking, which revealed a drug score of 0.88 and pi-alkyl linkages dominating the structure. A total of nine formulations were developed and characterized using the emulsification principle. Fluorescence spectra demonstrated complexation and interaction between CL and cationic BSA, which is highlighted by a decrease in fluorescence intensity. The drug loading of nanoemulsions ranged from 48.35 to 74.63%, and DAT displayed lesser CL entrapment than BSA formulations. The formulation “F1” containing a suitable amount of BSA, DAT, PLGA and MCC 200 found to be the optimum development with a mean globular size of 611.3 nm. An in-vitro investigation was performed for "F1"utilizing the Franz diffusion cell, which prolonged CL release while preserving the minimum effective concentration. Nanoemulsion "F1" was examined using a scanning electron microscope, zeta potentialvalue, attenuated total reflectance, differential scanning colorimetry, and X-ray diffraction. Using the Morris Water Maze (MWM) model, learning and memory ability of Alzheimer's disease (AD)-induced Long-Evans rats were observed, with significant satisfactory results for the selected formulation; which is validated by analysis of variance (ANOVA). Based on the findings, the present study concludes that, a suitable combination of CL-DAT-BSA and PLGA could be used to effectively deliver and enhance the therapeutic benefit in AD patients.
Biomass-Derived Mesoporous Carbon Nanomaterials for Drug Delivery and Imaging Applications
Biomass-Derived Carbon Materials, Nov 2022
The development of new biomaterial schemes offers a bright future for translating nanomaterials for personalized biomedicine into effective clinical treatments for patients. In contrast to conventional mesoporous silica, mesoporous carbon biomaterials combine the advantages of a mesoporous nanostructure and carbonaceous configuration, presenting superior potentials paralleled by other carbon-based nanomaterials such as fullerenes and carbon nanotubes. Graphene and its spinoffs include graphene oxide, nanodiamonds, and carbon-based quantum dots as well. These constituents have sparked considerable interest across a wide range of fields, including biological applications, because of their outstanding operational ranges and impressive mechanical, electrical, thermal, optical, and chemical capabilities. Scholars in the field of nanomedicine have long been interested in mesoporous carbon nanoparticles (MCNs). The near-infrared laser absorption enhanced by MCNs also suggests that light can be effectively translated into heat for anticancer therapy. When combined with photothermal treatment and synergistic therapies such as fluorescence labeling of tumor cells and bioadsorption of pathogenic toxic components, this technology thrives for on-demand drug release as well as photothermal therapy and synergistic therapies. Graphene and its derivatives have been proposed as bioimaging agents in numerous researches. Because of the inherent two-photon fluorescence property of carbon-based nanomaterials, this application is advanced and permits the use of deep tissue imaging agents for tumor diagnosis in the near-infrared II wavelength area. These MCNs could pave the way for a new generation of nanodevices, according to our predictions. Solicitations based on their specific nanostructure, arrangement, and biocompatibility are used for transmembrane and intracellular delivery. As a final point, possible obstacles and stances for future advances in biological sectors of mesoporous carbon must be given consideration.
Chitosan based urapidil microparticle development in approach to improve mechanical strength by cold hyperosmotic dextrose solution technique
Journal of Drug Delivery Science and Technology, Oct 2022
The objective of the study deal with chitosan based microparticle utilizing a novel method mentioned as cold hyperosmotic dextrose solution treatment. The poor mechanical strength of chitosan especially degradation in relation to pH of the medium, poor performance in extended release form as mentioned in literature solved. Microparticles formulated by ion cross-linking technique utilizing chitosan as cationic and small anions such as sodium citrate (SC), sodium sulphate (SS) and sodium tripolyphosphate (STPP) as cross-linkers. Anionic solutions were maintained at 20% w/v along with Dextrose (40% w/v, 15 °C and 2.02 Osmol). The prepared beads were collected on filtration and dried to get microparticles; furthermore subjected for characterization. Those were characterized for surface morphology, entrapment efficiency, and adhesive strength by texture analyzer, in-vitro release study, swelling index, ATR-FTIR, DSC, XRD and in-vivo antihypertensive study by Tail-cuff method. SEM study revealed non symmetrical appearance and porus structure especially in STPP formulation. However, entrapment gradually decreased with increase in chitosan. Whereas, texture analyzer exhibited gradual increase in adhesive strength which indicate obvious improvement in mechanical strength. Similarly, formulations were able prolonged the drug release for sufficient period of time; SC1 exhibited 72.59% at 44 h. From each group the formulation extended rug release for long period subjected to swelling index study; STPP continued to swell as compared to SC and SS. Mean particle size found to be 1.07 μm, 1.35 μm, and 2.17 μm for SC1, SS2 and TP1 microparticles respectively. The selected formulation “SC1” effectively reduced elevated blood pressure as observed in Tail-cuff method.
An insight of nanogels as novel drug delivery system with potential hybrid nanogel applications
Journal of Biomaterials Science, Polymer Edition, Oct 2021
Nanogels are cross-linked, nano-sized hydrogels with dimensions ranging from 20 to 200 nm. Nanogel-based nanoplatforms have proven to be an excellent choice for pharmaceutical formulations. Nanosystems have properties that are very useful in polymeric drug delivery applications, and their particular strength is that they have these nanosystemic properties and can thus merge with polymeric materials. Drug-carrier size is designed to be nano-sized in order to maintain optimal stability, resulting in more surface area and interior space. This also allows for a prolonged period of time for loaded pharmaceuticals to circulate. They can be classified by stimuli responsive or non-responsive behavior and type of linkages present in the network chains of gel structure. Nanogel can be synthesized by Photolithographic, modified pullulan, emulsion polymerization reverse microemulsion polymerization inverse miniemulsion polymerization and free radical crosslinking polymerization technique. Hybrid nanogels are different from conventional polymer nanoparticles often employed for drug administration. They can encapsulate bioactive medicines and regulate the release of such medications over time and in particular areas. The hybrid nanogels used to create a specific form of the hybrid, especially one geared towards increasing targeted drug delivery, enhance the effectiveness of ailment treatments, but perhaps the introduction of a multifunctional nanogel-based drug delivery system.
Advantages and limitations of functionalized nanomaterials based electrochemical sensors environmental monitoring
Functionalized Nanomaterial-Based Electrochemical Sensors, Oct 2022
An extensive array of toxic chemicals is presently unconstrained into the environment in footings of airborne, aquatic, and solid wastes due to the swift international globalization and industrialization. Consequently, a sensitive, reliable, and cost-effective sensor platform for evolving environmental pollutants is of prodigious prominence. The significant encroachments obligate made on the effective electrochemical sensor platform centered on nanomaterials for environmental monitoring. Electrochemical sensors are currently extensively admitted as a sensitive exposure tool for disease diagnosis as well as the revealing of abundant species of pharmaceutical, clinical, industrial, food, and environmental origin. Nanomaterials have capable of impending to surge competitiveness of electrochemical sensors in environmental monitoring, though investigation has engrossed chiefly on advance of practice for devising new sensors, and the number of revisions for enhancing the enactment of sensors and the applicability to real samples is still inadequate. The substantial advance of the nanomaterials-based electrochemical sensor platforms is a bountiful rise to new push of generating novel technologies for securing the human and environmental safety. In the field of environmental monitoring, nanomaterials-based sensors exhibited great potentials in trace pollutants detection because nanomaterials possess large surface area, high surface reactivity, high catalytic efficiency, strong adsorption capacity. In this chapter, the recent trends in the development of the electrochemical sensor platforms-based nanomaterials such as metal nanoparticles, metal oxide nanomaterials, carbon nanomaterials, polymer, and biomaterials are considered.
3D Printing Technology in Pharmaceutical Dosage Forms: Advantages and Challenges
Current Drug Targets, Dec 2021
Three Dimensional (3D) printing is a promising method for quick prototyping and manufacturing of any material. It is similar to photocopy or printing, where the new materials are formed on layers (3D) like their mother component. Following its growth and advancement in the 1980s, its application in pharmaceuticals is still limited. It has become one of the most innovative and influential tools serving as a technology for developing dosage forms from the last decade. The potential of 3D printing to produce drugs for precise measurement customized to specific patients' needs has shown the possibility of developing personalized medicines to novel dosage forms. The breakthrough allows the clear perception of the dosage structures on different shapes, sizes, surfaces and the associated challenges in delivering them by using such designed conditions. There are different difficulties related to the correct utilization of 3D imprinting in the pharmaceuticals, which have a strong impact on the scope of this technology. Recent advancements in the field of 3D printing technology used in the pharmaceutical industry mainly focused on different techniques for the fabrication of different dosage forms. The Food and Drug Administration's (FDA) recent approval of the first 3D prescription highlights possibilities for 3D printing innovation in the field of pharmaceutical drug supply. This analysis assesses 3D printing advancement possibilities, particularly in the area of custom prescriptions. This technology can be regarded as the future produced on demand, low-cost solid dosage forms and helps minimize side effects due to overdose.
Design expert assisted formulation, characterization and optimization of microemulsion based solid lipid nanoparticles of repaglinide
Progress in Biomaterials, Nov 2021
Repaglinide, a member of the meglitinide class of drugs, is a new anti-diabetic agent that is utilized as an oral hypoglycemic agent. Using glyceryl monostearate, cetyl palmitate, and tristearin as lipids and poloxamer 188 as a surfactant, repaglinide-loaded solid lipid nanoparticles were created. Solid lipid nanoparticles were prepared utilizing an o/w microemulsion technique, which included the lipids glyceryl monostearate and tristearin, as well as waxes such as cetyl palmitate and the surfactant poloxamer 188. The mean particle size of the solid lipid nanoparticles formed was around 339 nm, with an entrapment efficiency of 82.20%. In-vitro release studies continued to be conducted using the dialysis bag diffusion technique. Within 12 h, the cumulative drug release was 88.4%. The results indicate that repaglinide was released more slowly from solid lipid nanoparticles made from tristearin and glyceryl monostearate in an equal ratio. Tristearin found the controlled release and extreme entrapment from other lipid carriers like glyceryl monostearate and cetyl palmitate. Differential scanning calorimetry demonstrates that repaglinide is entangled in amorphous or molecular state within solid lipid nanoparticles. SEM microscopy revealed that the produced repaglinide solid lipid nanoparticles had a spherical shape. After one month of storage at 2–8 °C, short-term stability testing revealed no significant alteration.
The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
Drug discovery today, Jul 2021
Triple-negative breast cancers (TNBCs) form a heterogeneous group of breast carcinomas that lack expression of estrogen receptor, progesterone receptor and epidermal growth factor receptor 2. In the past decade, immune checkpoint inhibitors (ICIs) have revolutionized the arena of cancer immunotherapy. Early results are now accumulating from trials involving the treatment of TNBCs with radical ICIs therapies, including combinational therapies that include ICI technologies. In this review, we provide a broad overview of the progress of immunotherapy-based treatments and discuss future opportunities for their use in TNBC.
Solubility enhancement, formulation development and antifungal activity of luliconazole niosomal gel-based system
Journal of Biomaterials Science, Polymer Edition , Mar 2021
Luliconazole is a potential prescription candidate drug for the treatment of topical fungal infections. However, it has water solubility and skin permeability limitations. To overcome these limitations, a niosomal gel of luliconazole was formulated using Span 60, cholesterol, and chloroform to improve its bioavailability and to reduce its toxicity. Niosomes were analyzed by transmission electron microscopy (TEM) and Fourier transform infrared spectroscopy (FTIR) for morphological and spectral studies respectively. The formulations had ideal nanometric vesicle sizes, encapsulation efficiency (88.891% ± 0.0364%), Zeta potential (−40.1 mV), and storage instability was not observed. The sustained-release profile of niosomal gel was observed for up to 24 h. The highest R2 value was 0.913; the Higuchi model was considered the best fit model for the niosomal formulations. Cytotoxicity studies confirmed the biocompatibility of the niosomal gel of luliconazole. Based on the results, it can be concluded that niosomal luliconazole may enhance the activity of luliconazole against Candida albicans (C. albicans).
Formulation and evaluation of thermosensitive flurbiprofen in situ nano gel for the ocular delivery
Journal of Biomaterials Science, Polymer Edition , May 2021
The contemporary research implicates the formulation and evaluation of a thermosensitive in situ nano gelling method to improve solubility and ocular residence time of flurbiprofen. This study was carried out in two phases. In the first phase, an insolubility drug has been formulated in the form of a nanoparticulate system and evaluated for its characteristics. The nanoparticles obtained demonstrated an average size array of 150 to 250 nm in diameter, up to 79.35% encapsulation efficiency, and up to 93.42% drug release throughout 2 h. In the second phase, nanoparticulate systems were dispersed in aqueous solutions of Pluronic F 127 (14%) and various concentrations of Carbopol 934 in combination to form an in situ nano gel. The prepared in situ gel was investigated for its physicochemical properties like pH, flowability, sol-gel transition temperature, gelling capacity, and rheological properties. Carbopol 934 did not significantly affect sol-gel transition temperature in optimized concentration (<0.3%) but altered gelling capacity, pH, and transparency of the formulations. In vivo resident time and eye irritation test was evaluated in the rabbit eye. In optimized in situ gelling formulation (NIGF3), approximately 95% of in vitro drug release was observed after 6 h. NIGF3 increased precorneal residence time and high concentration in aqueous humor when paralleled to flurbiprofen eye drops. Greater concentration of drug in aqueous humor was due to its improved saturation solubility of the drug, and amplified residence time was attributed to the formation of gel matrix-embedded nanoparticles. This demonstrated that in situ nano gels (NIGF3) comprehending aqueous solutions of 0.3% w/v concentrations of Carbopol 934 with Pluronic F 127 may ominously persist the residence time and mend bioavailability of a water-insoluble drug.
Rationally engineered nanosensors: A novel strategy for the detection of heavy metal ions in the environment
Journal of Hazardous Materials, May 2021
Heavy metal ions (HMIs) have been mainly originated from natural and anthropogenic agents. It has become one of biggest societal issues due to their recognised accumulative and toxic effects in the environment as well as biological media. Key measures are required to reduce the risks posed by toxic metal pollutants existing in the environment. The increased research activities of HMIs detection, and use of technologies based on electrochemical detection that combine with engineered nanomaterials, is a key promising and innovative strategy that can potentially confine heavy metal poisoning. Deep understanding of the characteristics of the physicochemical properties of nanomaterials is highly required. It is also important to interpret the parameters at the nano-bio interface level that merely affect cross-interactions between nanomaterials and HMIs. Therefore, the authors outlined the state-of-the-art techniques that used engineeringly developed nanomaterials to detect HMIs in the environment. The possible novel applications of extensive and relatively low-cost HMIs monitoring and detection are discussed on the basis of these strengths. Finally, it is concluded by providing gist on acquaintance with facts in the present-day scenario along with highlighting areas to explore the strategies to overcome the current limitations for practical applications is useful in further generations of nano-world.
Formulation development and characterization of enteric coated tablets of lansoprazole
Der Pharmacia Lettre, May 2021
Fate and Applications of Superporous Hydrogel Systems: A Review
Current Nanomedicine (Formerly: Recent Patents on Nanomedicine), Dec 2020
Hydrogels are a class of biomaterial that can “take in” large quantities of aqueous media and swells many times larger than its original size without dissolving in the media. SPHs are a new generation of hydrogels containing a 3D network of cross-linked polymers having pore size more than 100 μm as compared to 10 nm to 10 μm pores of conventional gels. These are more complex in nature than conventional hydrogels and prepared by using a suitable blend of monomers and different additives. SPHs have been extensively employed in sustained and control drug delivery systems along with many recent biomedical applications such as in tissue engineering, immunotherapy, arthritis and ophthalmic drug delivery. Scientists are constantly working on improving the features and properties of SPHs to enable them more suitable for therapeutic and biomedical applications. The present study briefly reviews the composition, evaluation and applications of SPHs in different areas. Applications are facilitated by the fact that SPHs are generally biocompatible in nature and resemble natural living tissue more than any other class of synthetic biomaterial.
Formulation and evaluation of gastro-retentive floating bilayer tablet for the treatment of hypertension
Heliyon, Nov 2020
The paper aimed to progress an ideal gastro retentive drug delivery system intended for directing Losartan and Hydrochlorothiazide as a fixed-dose combination for anti-hypertensive therapy. The bilayer tablets were primed through direct compression method. Losartan was formulated by means of a floating layer expending hydrophilic swellable polymer Hydroxy Propyl Methyl Cellulose K4M, ethyl cellulose (4cps) as a buoyancy enhancer, sodium bicarbonate as a gas spawning agent. The amount of polymer blends remains optimized using 23 full factorial designs. The clout of experimental factors such as swelling agent concentration, buoyancy enhancer and gas generating agent on floating lag time, total floating time, T50% and % drug release remain investigated to get optimized formulation. The responses remain analyzed using Analysis of variance, and polynomial equation stood created for every retort using Multiple linear regression analysis. Entirely preparations floated for more than 12 h. The release pattern of losartan stood fitted to diverse models based on the coefficient of correlation (r). All the formulations, except F2, showed the Korsemeyer-Peppas model as the best fit model. Formulation F2 showed the zero-order model. Diffusion exponents (n) remained indomitable designed for entirely formulations (0.45–0.89), accordingly the chief drug discharge mechanism was non-fickian (anamolous) transport. Formulation F4 containing 20% w/w Hydroxy Propyl Methyl Cellulose K4M, 15% Sodium bicarbonate and 5% ethyl cellulose (4cps) was the best formulation as per the range of drug release remain institute to be more than 95 % in 12h and floating lag time was 20.15 s. The immediate-release layer stood optimized using crospovidone and Indion 414 as a super disintegrant. Formulation A8 containing 2% Indion 414 was considered as optimized formulation as it released 99% drug within 35 min and possessed less disintegration time. Optimized formulation F4 from the controlled-release layer and A8 from immediate-release layer was used to formulate bilayer tablet. The optimized formulation was imperilled to stability reading for three months at 40○C/75% relative humidity. The stability revision exhibited no substantial alteration in the appearance of tablets, floating characteristics, drug content and in-vitro drug dissolution. Consequently, a biphasic drug release design was effectively accomplished over the formulation of floating bilayer tablets.
Enhancing the solubility of nitazoxanide with solid dispersions technique: formulation, evaluation, and cytotoxicity study
Journal of Biomaterials Science, Polymer Edition, Nov 2020
Nitazoxanide (NTZ) is a synthetic form of nitrothiazole with a broad range of applications as an antiparasitic, antibacterial and antiviral agent. NTZ is a highly low aqueous soluble drug which possesses solubility of 0.00755 mg/mL and typically low bioavailability of 1%. Low aqueous solubility is usually regarded as prime prerequisites for enhanced absorption and bioavailability. The purpose of this study is to improve in vitro dissolution of the poorly soluble drug NTZ through amorphous solid dispersion technology. Three solid dispersions of NTZ were successfully prepared by hot-melt technique. It was further evaluated for drug content, DSC, XRD, SEM, TEM, FT-IR, in-vitro drug release study, in vitro MTT safety on HEK-293 and A-549 and stability study. The results of XRD showed after the formation of solid dispersions. The number of crystalline peaks has disappeared and confirmed the amorphous form of the drug. An in vitro release study showed that NTZ effectively released from solid dispersion into a simulated gastric releasing medium (pH 1.2). Further, the cytotoxicity study gave an indication of safe for human. Also, stability studies depicted no evident difference in the physical state of solid dispersion after six months. Hence, it can be concluded that the newly developed formulation was found to be safe and stable with enhanced solubility profile.
Turn-on fluorescence sensor for selective detection of fluoride ion and its molecular logic gates behavior
Journal of Molecular Liquids, Nov 2020
Loutonin based emissive probe (L) for the dual sensing of fluoride (F−) and bisulphate (HSO4−) anions in aqueous media. The development is based on reports that the interaction between fluoride and loutonin based fluorescent probe exhibits rapid and remarkable color changes in both colorimetrically as well as fluorimetrically. More amusingly, on the introduction of bisulphate ion into the medium containing loutonin fluoride ion complex (L-F−) which shows both the color and fluorescence has been recovered. The limit of detection for fluoride ions by the probe was determined as 8.62 × 10−7 M by fluorescence titrations. Further the probe L can be employed for the removal of fluoride ions. The need for a dual anion detection system with such an outstanding reversible and reproducible process characteristics led us to consider loutonin as a feasible nominee for the construction of molecular keypad lock and molecular logic circuits. The fluorescence change of loutonin after appendage of fluoride ions is mainly due to the hydrogen bonding interaction. Further, the probe could be potentially incorporated into the test strips and silica gel plates, with better selectivity for fluoride and bisulphate anions in aqueous media.
Integration of pharmacogenomics and theranostics with nanotechnology as quality by design (QbD) approach for formulation development of novel dosage forms for effective drug therapy
journal of controlled release, Nov 2020
To cater to medication needs in the future healthcare system, we need to shift from the conventional system of drug delivery to modern molecular signature-based drug delivery systems. The current drug therapies are either less effective, ineffective, or produce numerous adverse reactions. One scientific principle or discipline cannot adequately address all the problems, so we need an innovative application of the current scientific principles. Here we are proposing a novel concept of nanoformulation based on pharmacogenomics and theranostics for personalized error-free and targeted therapeutic agent delivery. The addition of more knowledge about the human genome opens the new way to study disease-gene, gene-drug, and drug-effect interactions, which is the basis of future medicines. Pharmacogenomics provides information about the disease etiology, role in genes in disease pathophysiology, disease biomarkers, drug targets, drug effects, and the fate of drugs inside the body. Theranostics approach utilizes the above information in diagnosis, treatment, and monitoring of the disease on a real-time basis. Personalized dosage forms can be formulated into a nanoformulation that provides a better therapeutic effect and minimizes adverse drug reactions. The therapeutic system needs to be shifted from the principle of one drug fits all to one drug unique population. In the present manuscript, we tried to conceptualize a modern therapeutic system by combining the three approaches viz. pharmacogenomics, theranostics, and nanotechnology applied in the area of formulation development to produce a multifunctional single tiny entity.
Formulation Development and Characterization of Controlled Release Core-in-cup Matrix Tablets of Venlafaxine HCl
Current drug therapy, Oct 2020
Background: Venlafaxine HCl is a selective serotonin reuptake inhibitor, which is given in the treatment of depression. The delivery of the drug at a controlled rate can be of great importance for a prolonged effect. Objective: The objective was to prepare and optimize the controlled release core in a cup matrix tablet of venlafaxine HCl using the combination of hydrophilic and hydrophobic polymers to prolong the effect with rate controlled drug release. Methods: The controlled release core in cup matrix tablets of venlafaxine HCl was prepared using HPMC K5, K4, K15, HCO, IPA, aerosol, magnesium stearate, hydrogenated castor oil and micro crystalline cellulose PVOK-900 using wet granulation technique. Total ten formulations with varying concentrations of polymers were prepared and evaluated for different physicochemical parameters such FTIR analysis for drug identification. In-vitro drug dissolution study was performed to evaluate the amount of drug release in 24 hrs, drug release kinetics study was performed to fit the data in zero order, first order, Hixson-crowell and Higuchi equation to determine the mechanism of drug release and stability studies for 3 months as observed. Results: The results of hardness, thickness, weight variation, friability and drug content study were in an acceptable range for all formulations. Based on the in vitro dissolution profile, formulation F-9was considered to be the optimized, extending the release of 98.32% of drug up to 24 hrs. The data fitting study showed that the optimized formulation followed the zero order release rate kinetics and when compared with the innovator product (flavix XR), showed better drug release profile. Conclusion: The core-in-cup technology has the potential to control the release rate of freely water soluble drugs for single administration per day by optimization with the combined use of hydrophilic and hydrophobic polymers.
A novel curcumin-loaded PLGA micromagnetic composite system for controlled and pH-responsive drug delivery
Colloids and Surfaces A: Physicochem. Eng. Aspects, Jul 2019
Poly(d, l-lactide-co-glycolic acid) (PLGA) based magnetic microspheres (MMS) hold immense potential for reaching the target of controlled and specific drug delivery site with low toxicity. Herein, we have synthesized the biodegradable PLGA microspheres (MS) containing magnetic iron oxide nanoparticles (MIONPs) by the emulsion solvent evaporation method and loaded (them) with the well-known anti-cancer drug, curcumin. The existing crystallinity of MIONPs in the MMS has been confirmed by powder XRD analysis. The prepared MMS displayed excellent superparamagnetism displaying a saturated magnetism with a value being 24.4 emu/g. The morphology of MS and MMS was found to have spherical shape along with a smooth surface of mean diameter of 0.5 μm and 1 μm (micrometer range). Moreover, the MIONPs content of 23.74 wt% in the MMS was evaluated referring TGA studies. However, the drug release profiles resulted that the MMS have a pH-induced drug-releasing asset with a cumulative CUR releasing efficiency of 73.25%. According to the results obtained from the cytotoxic studies, MMS has cytotoxicity against HeLa cell lines with a significant potency that is promising for targeted chemotherapeutic applications.
Rhodamine‐based fluorescent turn‐on probe for facile sensing and imaging of ATP in mitochondria
ChemistrySelect , Sep 2017
We have developed a “turn-on” fluorescent probe ARP-1 as a colorimetric and fluorescent chemosensor for adenosine-5’-triphosphate (ATP) through hydrogen bond interactions. The probe exhibits “turn-on” fluorescence response to ATP with a 15-fold fluorescence intensity enhancement under 10 equiv. of ATP added. The experimental results show that the response behavior of ARP-1 toward ATP is pH independent (pH 4.0-8.0). The novel chemosensor has high specificity towards ATP from other nucleoside polyphosphates such as ADP and AMP. The favorable interaction between a triphosphate unit of ATP and N atoms of probe ARP-1 is attributed to H-bonding. Consequently, the enhanced emission and naked-eye changes are attributed to spirolactam ring-opening. It is evident from our findings that the role of the chain length as well as the NH, OH groups and the phosphate group(s) contribute to interaction between the probe and the nucleotide. Cell permeability and selectivity towards ATP was demonstrated in HeLa Cells. Colocalization experiments were carried out with MitoTracker green and ARP-1 showing that the mitochondrion selective imaging ability of ARP-1. The live cell imaging experiments in HeLa cells exhibited high selectivity of probe ARP-1 with fluorescence turn-On response. ARP-1 could also be explored for understanding the cellular functions.
Rhodamine based effective chemosensor for Chromium(III) and their application in live cell imaging
Sensors and Actuators B: Chemical , Jul 2017
A novel easily available off-on fluorescent and colorimetric probe based on rhodamine was synthesized. It showed selective and sensitive recognition toward Cr3+in aqueous medium, with no significant interference of other competitive metal ions. The observed photophysical changes is due to the operation if internal charge transfer after addition of Cr(III) ions to the probe. Density functional calculations (DFT) supported the observed UV–vis absorption and fluorescence emission changes. Furthermore, the probe has been utilized for fluorescence imaging of Cr3+ in HeLa cells under physiological conditions.
The role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesic
International journal of nanomedicine, Apr 2016
Transdermal drug delivery systems have made significant contributions to the medical community, but have yet to completely substitute oral or parenteral delivery. Recently, various strategies have been used to augment the transdermal delivery of therapeutics. Primarily, they include iontophoresis, electrophoresis, sonophoresis, chemical permeation enhancers, microneedles, and vesicular systems. Among these strategies, elastic liposomes appear promising. Elastic vesicle scaffolds have been developed and evaluated as novel topical and transdermal delivery systems, with an infrastructure consisting of hydrophobic and hydrophilic moieties together, and as a result, such scaffolds can accommodate drug molecules with a wide range of solubility. High deformability of these vesicles provides for better penetration of intact vesicles. This system is much more efficient at delivering low- and high-molecular-weight drugs to the skin in terms of quantity and depth. In this work, elastic liposomes of Tramadol HCl were prepared using a solvent evaporation method with different surfactants and were characterized using microscopy, and particle size, shape, drug content, ex vivo release, and zeta potential were also calculated. The prepared elastic liposomes were found to be in the range of 152.4 nm with a zeta potential of −22.4 mV; the entrapment efficiencies of the selected formulation was found to be 79.71%±0.27%. All formulations in the form of a gel were evaluated for physicochemical properties and were found to be homogeneous with no grittiness, and the pH of all formulations was found to be neutral. The optimized selected elastic liposomal formulation followed the Higuchi equation and Fickian diffusion and released the drug for a period of 24 hours. The overall results provide much promise for the continued investigation of deformable vesicles as transdermal drug carriers.
Formulation and evaluation of atenolol floating bioadhesive system using optimized polymer blends
International journal of pharmaceutical investigation, Jun 2016
Introduction: Oral sustained release gastro retentive dosage forms offer several advantages for drugs having absorption from the upper gastrointestinal tract to improve the bioavailability of medications which have narrow absorption window. The aim of the study was to develop a floating bioadhesive drug delivery system exhibiting a unique combination of floatation and bioadhesion to prolong the residence in the stomach using atenolol as a model drug. Methods: Prior to compression, polymeric blend(s) were evaluated for flow properties. The tablets were prepared by direct compression method using bioadhesive polymer like Carbopol 934P and hydrophilic polymers like HPMC K4M, HPMC K15M, and HPMC K100M. The prepared tablets were evaluated for physical characteristics, bioadhesive strength, buoyancy lag time, swelling index and in vitro drug release studies. Results: The mean bioadhesive strength was found to be in the range of 16.2 to 52.1 gm. The optimized blend (F11) showed 92.3% drug releases after 24 hrs. Whilst, increase in concentration of carbopol 934P, bioadhesive strength and swelling index was increased with slow release. The n values of optimized formulations were found in the range of 0.631-0.719 indicating non-fickian anomalous type transport mechanism. Conclusion: The study aided in developing an ideal once-a-day gastro retentive floating drug delivery system with improved floating, swelling and bioadhesive characteristics with better bioavailability.
A novel dissolution media for testing drug release from a nanostructured polysaccharide-based colon specific drug delivery system: an approach to alternative colon media
International Journal of Nanomedicine, Mar 2016
The aim of this study was to develop a novel microbially triggered and animal-sparing dissolution method for testing of nanorough polysaccharide-based micron granules for colonic drug delivery. In this method, probiotic cultures of bacteria present in the colonic region were prepared and added to the dissolution media and compared with the performance of conventional dissolution methodologies (such as media with rat cecal and human fecal media). In this study, the predominant species (such as Bacteroides, Bifidobacterium, Lactobacillus species, Eubacterium and Streptococcus) were cultured in 12% w/v skimmed milk powder and 5% w/v grade “A” honey. Approximately 1010–1011 colony forming units m/L of probiotic culture was added to the dissolution media to test the drug release of polysaccharide-based formulations. A USP dissolution apparatus I/II using a gradient pH dissolution method was used to evaluate drug release from formulations meant for colonic drug delivery. Drug release of guar gum/Eudragit FS30D coated 5-fluorouracil granules was assessed under gastric and small intestine conditions within a simulated colonic environment involving fermentation testing with the probiotic culture. The results with the probiotic system were comparable to those obtained from the rat cecal and human fecal-based fermentation model, thereby suggesting that a probiotic dissolution method can be successfully applied for drug release testing of any polysaccharide-based oral formulation meant for colonic delivery. As such, this study significantly adds to the nanostructured biomaterials’ community by elucidating an easier assay for colonic drug delivery.
A rhodamine based “turn-on” fluorescent probe for Pb(ii) and live cell imaging
RSC advances, Dec 2015
A novel “turn-on” fluorescent chemosensor RDP-1 based on a rhodamine tri methoxy benzaldehyde conjugate was synthesized, which showed high selectivity and sensitivity towards recognition of Pb2+ in aqueous media over other metal ions and also color changes from colorless to pink, allowing colorimetric detection of Pb2+ by the naked eye. The sensitivity of probe RDP-1 towards Pb2+ was demonstrated in living cells, and can be used for selective imaging of Pb2+ in living cells.
A nanomedicine-promising approach to provide an appropriate colon-targeted drug delivery system for 5-fluorouracil
International Journal of Nanomedicine, Nov 2015
Targeted drug delivery plays a significant role in disease treatment associated with the colon, affording therapeutic responses for a prolonged period of time with low side effects. Colorectal cancer is the third most common cancer in both men and women with an estimated 102,480 cases of colon cancer and 40,340 cases of rectal cancer in 2013 as reported by the American Cancer Society. In the present investigation, we developed an improved oral delivery system for existing anticancer drugs meant for colon cancer via prebiotic and probiotic approaches. The system comprises three components, namely, nanoparticles of drug coated with natural materials such as guar gum, xanthan gum (that serve as prebiotics), and probiotics. The natural gums play a dual role of protecting the drug in the gastric as well as intestinal conditions to allow its release only in the colon. In vitro results obtained from these experiments indicated the successful targeted delivery of 5-fluorouracil to the colon. Electron microscopy results demonstrated that the prepared nanoparticles were spherical in shape and 200 nm in size. The in vitro release data indicated that the maximum release occurs at pH 7.2 and 7.4 with 93% of the drug released in the presence of 4% (w/v) of rat cecal content. In vivo results conclude a practical mechanism to maintain the integrity and intactness of the intestinal/colonic microflora, in the face of a “chemical attack” by oral colon-targeted drug delivery for colon cancer treatment.
Formulation and Characterization Of Polycarbophil Coated Mucoadhesive Microspheres of Repaglinide
Journal of Pharmaceutical Sciences and Research, Oct 2015
Type 2 diabetes mellitus is a heterogeneous disease of polygenic origin and involves both insulin secretion and peripheral insulin resistance. Studies have shown that post-meal hyperglycemic spikes are associated with increased cardiovascular mortality in type 2 diabetes. Over the past decade, a major interest in control of postprandial glucose excursion has emerged as critical parameter and a plethora of new medications that specifically target postprandial hyperglycemia were researched or commercialized. Repaglinide is an anti-diabetic, oral blood-glucose lowering drug of the meglitinide class used in the management of type-II diabetes mellitus. It is the first member of new class of oral hypo-glycaemics designed to normalize the meal time glucose excursions. Repaglinide induces rapid onset short lasting insulin release. Microsphere based carrier systems formulated by using polymer polycarbophil bearing strong mucoadhesive properties and readily biodegradable could be attractive strategy to implement. The purpose of this research work is to formulate polycarbophil coated mucoadhesive microspheres of repaglinide and systematically evaluate its in vitro characteristics for sustained glucose lowering effect and improvement in diabetic condition as compared to immediate release of repaglinide.
Collaborator Notes
No notes yet.
Sign in to write a note.